2020 Q1 Form 10-Q Financial Statement

#000143774920004524 Filed on March 06, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1
Revenue $494.1M $380.6M
YoY Change 29.81% -8.77%
Cost Of Revenue $417.3M $315.9M
YoY Change 32.1% -7.69%
Gross Profit $76.70M $64.70M
YoY Change 18.55% -13.62%
Gross Profit Margin 15.52% 17.0%
Selling, General & Admin $60.40M $60.40M
YoY Change 0.0% -3.21%
% of Gross Profit 78.75% 93.35%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.279M $979.0K
YoY Change 30.64% 23.92%
% of Gross Profit 1.67% 1.51%
Operating Expenses $60.70M $60.60M
YoY Change 0.17% -3.5%
Operating Profit $16.00M $4.100M
YoY Change 290.24% -66.12%
Interest Expense -$33.00M -$21.20M
YoY Change 55.66% -50.23%
% of Operating Profit -206.25% -517.07%
Other Income/Expense, Net
YoY Change
Pretax Income -$7.436M -$17.11M
YoY Change -56.53% -43.86%
Income Tax $1.712M $346.0K
% Of Pretax Income
Net Earnings -$9.148M -$17.45M
YoY Change -47.58% -43.35%
Net Earnings / Revenue -1.85% -4.59%
Basic Earnings Per Share -$1.49 -$0.12
Diluted Earnings Per Share -$1.49 -$0.12
COMMON SHARES
Basic Shares Outstanding 6.160M 5.958M
Diluted Shares Outstanding 6.160M 149.0M

Balance Sheet

Concept 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $81.40M $113.3M
YoY Change -28.16% -59.87%
Cash & Equivalents $127.9M $153.2M
Short-Term Investments
Other Short-Term Assets $71.30M $42.90M
YoY Change 66.2% -1.38%
Inventory $1.296B $1.178B
Prepaid Expenses
Receivables $49.20M $32.70M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.498B $1.367B
YoY Change 9.53% -4.59%
LONG-TERM ASSETS
Property, Plant & Equipment $19.70M $20.30M
YoY Change -2.96% 4.1%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $135.3M $128.9M
YoY Change 4.97% 39.65%
Other Assets $19.90M $12.80M
YoY Change 55.47% 300.0%
Total Long-Term Assets $292.4M $256.4M
YoY Change 14.03% 20.48%
TOTAL ASSETS
Total Short-Term Assets $1.498B $1.367B
Total Long-Term Assets $292.4M $256.4M
Total Assets $1.790B $1.624B
YoY Change 10.24% -1.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $136.9M $116.4M
YoY Change 17.61% 8.58%
Accrued Expenses $95.20M $37.30M
YoY Change 155.23% 3.04%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $269.4M $187.9M
YoY Change 43.37% 4.39%
LONG-TERM LIABILITIES
Long-Term Debt $1.666B $1.637B
YoY Change 1.77% -1.49%
Other Long-Term Liabilities $353.7M $269.3M
YoY Change 31.34% -8.84%
Total Long-Term Liabilities $2.020B $1.906B
YoY Change 5.95% -2.6%
TOTAL LIABILITIES
Total Short-Term Liabilities $269.4M $187.9M
Total Long-Term Liabilities $2.020B $1.906B
Total Liabilities $2.289B $2.094B
YoY Change 9.31% -2.01%
SHAREHOLDERS EQUITY
Retained Earnings -$1.235B -$1.201B
YoY Change 2.81% -1.47%
Common Stock $715.3M $709.4M
YoY Change 0.84% 0.42%
Preferred Stock
YoY Change
Treasury Stock (at cost) $115.4M $115.4M
YoY Change 0.0% 0.0%
Treasury Stock Shares
Shareholders Equity -$499.8M -$470.4M
YoY Change
Total Liabilities & Shareholders Equity $1.790B $1.624B
YoY Change 10.24% -1.35%

Cashflow Statement

Concept 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income -$9.148M -$17.45M
YoY Change -47.58% -43.35%
Depreciation, Depletion And Amortization $1.279M $979.0K
YoY Change 30.64% 23.92%
Cash From Operating Activities $27.64M -$122.2M
YoY Change -122.63% 39.4%
INVESTING ACTIVITIES
Capital Expenditures $809.0K $1.019M
YoY Change -20.61% -46.82%
Acquisitions
YoY Change
Other Investing Activities -$16.00M $4.400M
YoY Change -463.64% -89.72%
Cash From Investing Activities -$16.80M $3.394M
YoY Change -595.08% -91.7%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$65.16M 38.96M
YoY Change -267.25% -126.77%
NET CHANGE
Cash From Operating Activities $27.64M -122.2M
Cash From Investing Activities -$16.80M 3.394M
Cash From Financing Activities -$65.16M 38.96M
Net Change In Cash -$54.32M -79.82M
YoY Change -31.95% -58.5%
FREE CASH FLOW
Cash From Operating Activities $27.64M -$122.2M
Capital Expenditures $809.0K $1.019M
Free Cash Flow $26.84M -$123.2M
YoY Change -121.78% 37.55%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 hov Aggregate Retention For Construction Defects Warranty And Bodily Injury Claims
AggregateRetentionForConstructionDefectsWarrantyAndBodilyInjuryClaims
20000000
CY2019Q1 hov Aggregate Retention For Construction Defects Warranty And Bodily Injury Claims
AggregateRetentionForConstructionDefectsWarrantyAndBodilyInjuryClaims
20000000
CY2020Q1 hov Allocated Share Based Compensation Income
AllocatedShareBasedCompensationIncome
100000
CY2020Q1 hov Bodily Injury Insurance Deductible
BodilyInjuryInsuranceDeductible
250000
CY2019Q1 hov Bodily Injury Insurance Deductible
BodilyInjuryInsuranceDeductible
250000
CY2020Q1 hov Bodily Injury Insurance Limit
BodilyInjuryInsuranceLimit
5000000
CY2019Q1 hov Bodily Injury Insurance Limit
BodilyInjuryInsuranceLimit
5000000
CY2020Q1 hov Carrying Value Of Communities Tested For Impairment
CarryingValueOfCommunitiesTestedForImpairment
600000
CY2019Q1 hov Proceeds From Model Sale Leaseback Financing Programs
ProceedsFromModelSaleLeasebackFinancingPrograms
9567000
CY2020Q1 hov Proceeds From Transfer Of Land To Joint Venture
ProceedsFromTransferOfLandToJointVenture
29800000
CY2020Q1 hov Purchase Price Associated With Land And Lot Options Of Unconsolidated Variable Interest Entities
PurchasePriceAssociatedWithLandAndLotOptionsOfUnconsolidatedVariableInterestEntities
1300000000
CY2020Q1 hov Real Estate Inventory Capitalized Interest Costs Interest Contributed To Joint Venture
RealEstateInventoryCapitalizedInterestCostsInterestContributedToJointVenture
4580000
CY2019Q1 hov Real Estate Inventory Capitalized Interest Costs Interest Contributed To Joint Venture
RealEstateInventoryCapitalizedInterestCostsInterestContributedToJointVenture
CY2020Q1 hov Real Estate Inventory Expense Not Eligible For Capitalization
RealEstateInventoryExpenseNotEligibleForCapitalization
25003000
CY2019Q1 hov Real Estate Inventory Expense Not Eligible For Capitalization
RealEstateInventoryExpenseNotEligibleForCapitalization
22273000
CY2020Q1 hov Cash Received From Subcontractors For Owner Controlled Insurance Program
CashReceivedFromSubcontractorsForOwnerControlledInsuranceProgram
1300000
CY2019Q1 hov Cash Received From Subcontractors For Owner Controlled Insurance Program
CashReceivedFromSubcontractorsForOwnerControlledInsuranceProgram
1200000
CY2020Q1 hov Changes In Noncontrolling Interest In Consolidated Joint Ventures
ChangesInNoncontrollingInterestInConsolidatedJointVentures
13000
CY2020Q1 hov Common Stock Dividends Percent Of Increase From Class A To Class B
CommonStockDividendsPercentOfIncreaseFromClassAToClassB
1.1
CY2020Q1 hov Conversion Of Stock From Class B To Class A Conversion Ratio
ConversionOfStockFromClassBToClassAConversionRatio
1
CY2019Q1 hov Conversion Of Stock From Class B To Class A Conversion Ratio
ConversionOfStockFromClassBToClassAConversionRatio
1
CY2020Q1 hov Conversion Of Stock Value
ConversionOfStockValue
CY2019Q1 hov Conversion Of Stock Value
ConversionOfStockValue
CY2020Q1 hov Corporate General And Administrative
CorporateGeneralAndAdministrative
19744000
CY2019Q1 hov Corporate General And Administrative
CorporateGeneralAndAdministrative
17664000
CY2020Q1 hov Debt Covenant Fixed Charge Coverage Ratio Minimum
DebtCovenantFixedChargeCoverageRatioMinimum
2
CY2020Q1 hov Deposits Associated With Land And Lot Options Of Unconsolidated Variable Interest Entities
DepositsAssociatedWithLandAndLotOptionsOfUnconsolidatedVariableInterestEntities
74300000
CY2020Q1 hov General Liability Insurance Deductible
GeneralLiabilityInsuranceDeductible
20000000
CY2019Q1 hov General Liability Insurance Deductible
GeneralLiabilityInsuranceDeductible
20000000
CY2020Q1 hov Inventory Impairments And Land Option Cost Write Offs
InventoryImpairmentsAndLandOptionCostWriteOffs
2828000
CY2019Q1 hov Inventory Impairments And Land Option Cost Write Offs
InventoryImpairmentsAndLandOptionCostWriteOffs
704000
CY2020Q1 hov Joint Venture Total Debt To Capitalization Ratio
JointVentureTotalDebtToCapitalizationRatio
0.32
CY2020Q1 hov Loans Held For Sale Mortgages Unpaid Principal
LoansHeldForSaleMortgagesUnpaidPrincipal
86500000
CY2019Q4 hov Loans Held For Sale Mortgages Unpaid Principal
LoansHeldForSaleMortgagesUnpaidPrincipal
161100000
CY2020Q1 hov Noncash Portion Of Lease Expense
NoncashPortionOfLeaseExpense
2316000
CY2020Q1 hov Noncontrolling Interest Income In Consolidated Joint Venture
NoncontrollingInterestIncomeInConsolidatedJointVenture
-13000
CY2019Q1 hov Noncontrolling Interest Income In Consolidated Joint Venture
NoncontrollingInterestIncomeInConsolidatedJointVenture
CY2020Q1 hov Number Of Communities Evaluated For Impairment
NumberOfCommunitiesEvaluatedForImpairment
383
CY2019Q1 hov Number Of Communities Evaluated For Impairment
NumberOfCommunitiesEvaluatedForImpairment
397
CY2020Q1 hov Number Of Communities Performed Detailed Impairment Calculations
NumberOfCommunitiesPerformedDetailedImpairmentCalculations
1
CY2020Q1 hov Number Of Loans Reserved For
NumberOfLoansReservedFor
21
CY2019Q1 hov Number Of Loans Reserved For
NumberOfLoansReservedFor
20
CY2020Q1 hov Number Of Owned Active Communities Transferred To The Joint Venture
NumberOfOwnedActiveCommunitiesTransferredToTheJointVenture
4
CY2020Q1 hov Number Of Owned Communities Transferred To The Joint Venture
NumberOfOwnedCommunitiesTransferredToTheJointVenture
8
CY2020Q1 hov Payment Of Financing Costs For Debt Issuance And Land Bank Financing
PaymentOfFinancingCostsForDebtIssuanceAndLandBankFinancing
10637000
CY2019Q1 hov Payment Of Financing Costs For Debt Issuance And Land Bank Financing
PaymentOfFinancingCostsForDebtIssuanceAndLandBankFinancing
1489000
CY2020Q1 hov Payments By Insurance Companies For Claims
PaymentsByInsuranceCompaniesForClaims
100000
CY2019Q1 hov Payments By Insurance Companies For Claims
PaymentsByInsuranceCompaniesForClaims
100000
CY2020Q1 hov Payments For Land Bank Financing Program
PaymentsForLandBankFinancingProgram
23544000
CY2019Q1 hov Payments For Land Bank Financing Program
PaymentsForLandBankFinancingProgram
3193000
CY2020Q1 hov Payments For Model Sale Leaseback Financing Programs
PaymentsForModelSaleLeasebackFinancingPrograms
7474000
CY2019Q1 hov Payments For Model Sale Leaseback Financing Programs
PaymentsForModelSaleLeasebackFinancingPrograms
1860000
CY2020Q1 hov Payments Settlements
PaymentsSettlements
CY2019Q1 hov Payments Settlements
PaymentsSettlements
-1350000
CY2020Q1 hov Proceeds From Land Bank Financing Program
ProceedsFromLandBankFinancingProgram
39620000
CY2019Q1 hov Proceeds From Land Bank Financing Program
ProceedsFromLandBankFinancingProgram
14626000
CY2020Q1 hov Proceeds From Model Sale Leaseback Financing Programs
ProceedsFromModelSaleLeasebackFinancingPrograms
2368000
CY2020Q1 hov Secured Debt Leverage Ratio
SecuredDebtLeverageRatio
4
CY2020Q1 hov Sharebased Payment Arrangement Noncash Expense Income Total
SharebasedPaymentArrangementNoncashExpenseIncomeTotal
-116000
CY2019Q1 hov Sharebased Payment Arrangement Noncash Expense Income Total
SharebasedPaymentArrangementNoncashExpenseIncomeTotal
615000
CY2018Q1 hov Shareholder Ownership Percentage Of Increase
ShareholderOwnershipPercentageOfIncrease
0.5
CY2020Q1 hov Stock Issued During Period Value Restricted Stock Awards Net Of Forfeitures And Adjustments To Additional Paid In Capital Share Based Compensation Requisite Service Period Recognition Value
StockIssuedDuringPeriodValueRestrictedStockAwardsNetOfForfeituresAndAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionValue
-330000
CY2019Q1 hov Stock Issued During Period Value Restricted Stock Awards Net Of Forfeitures And Adjustments To Additional Paid In Capital Share Based Compensation Requisite Service Period Recognition Value
StockIssuedDuringPeriodValueRestrictedStockAwardsNetOfForfeituresAndAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionValue
485000
CY2020Q1 hov Stock Options Amortization And Issuance Value
StockOptionsAmortizationAndIssuanceValue
162000
CY2019Q1 hov Stock Options Amortization And Issuance Value
StockOptionsAmortizationAndIssuanceValue
107000
CY2020Q1 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
4015000
CY2019Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
2301000
CY2020Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
715336000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
715504000
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
600000
CY2019Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
600000
CY2020Q1 us-gaap Allowance For Loan And Lease Losses Adjustments Net
AllowanceForLoanAndLeaseLossesAdjustmentsNet
CY2019Q1 us-gaap Allowance For Loan And Lease Losses Adjustments Net
AllowanceForLoanAndLeaseLossesAdjustmentsNet
10000
CY2020Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1281000
CY2019Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1820000
CY2020Q1 us-gaap Assets
Assets
1790003000
CY2019Q4 us-gaap Assets
Assets
1881424000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
182266000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
232992000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
127948000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
153173000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-54318000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-79819000
CY2020Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
64400000
CY2019Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
143100000
CY2020Q1 us-gaap Costs And Expenses
CostsAndExpenses
512488000
CY2019Q1 us-gaap Costs And Expenses
CostsAndExpenses
407262000
CY2020Q1 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
1265572000
CY2019Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
1310638000
CY2020Q1 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
23503000
CY2019Q4 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
-49145000
CY2020Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
24552000
CY2019Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
19970000
CY2020Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
596000000
CY2020Q1 us-gaap Depreciation
Depreciation
1279000
CY2019Q1 us-gaap Depreciation
Depreciation
979000
CY2020Q1 us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: &quot;Times New Roman&quot;; font-size: 10pt; min-width: 700px;"> <tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; vertical-align: top;"> <td style="width: 18pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <div style=" margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19.</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <div style=" margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Recent Accounting Pronouncements</div></div> </td> </tr> </table> <div style=" margin: 0pt 22.4pt 0pt 14.7pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 45pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02,</div> &#x201c;Leases (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">842</div>)&#x201d; (&#x201c;ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02&#x201d;</div>), which provides guidance for accounting for leases. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> requires lessees to classify leases as either finance or operating leases and to record a right-of-use asset and a lease liability for all leases with a term greater than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12</div> months regardless of the lease classification. The lease classification will determine whether the lease expense is recognized based on an effective interest rate method or on a straight-line basis over the term of the lease. Accounting for lessors remains largely unchanged from current GAAP. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> was effective for the Company on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November 1, 2019 </div>and we applied the modified retrospective method of adoption, resulting in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> restatement of prior period financial statements. We elected the practical expedient package which allows us to carry forward our original assessment of whether contracts contained leases, lease classification and the initial direct costs. We also elected the practical expedient that allows lessees the option to account for lease and non-lease components together as a single component for all classes of underlying assets. The adoption of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> resulted in a gross up on our Condensed Consolidated Balance Sheets for ROU assets and lease liabilities of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$23.3</div> million and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$24.4</div> million, respectively, as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November 1, 2019. </div>Existing prepaid rent and accrued rent were recorded as an offset to the gross operating ROU assets. Our ROU assets are included in &#x201c;Prepaid expenses&nbsp;and other assets&#x201d; and the corresponding lease liabilities are included in &#x201c;Accounts payable and other liabilities&#x201d; line items on our Condensed Consolidated Balance Sheets. The adoption of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> impact on our condensed consolidated statements of operations or cash flows, nor did it have a significant impact on our business processes, systems or internal controls.</div> <div style=" margin: 0pt; text-align: left; text-indent: 45pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 45pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 2018, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09,</div> &#x201c;Codification Improvements&#x201d; (&#x201c;ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09&#x201d;</div>). ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> provides amendments to a wide variety of topics in the FASB&#x2019;s Accounting Standards Codification, which applies to all reporting entities within the scope of the affected accounting guidance. The transition and effective date guidance are&nbsp;based on the facts and circumstances of each amendment. Some of the amendments in ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> require transition guidance and were&nbsp;effective upon issuance of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09.</div> However, many of the amendments do have transition guidance with effective dates for annual periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2018. </div>The adoption of the applicable guidance of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have any significant impact on our Condensed Consolidated Financial Statements.</div> <div style=" margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 45pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 2018, </div>the FASB issued&nbsp;ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,</div> &#x201c;Fair Value Measurement (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">820</div>) - Disclosure Framework&#x201d; (&#x201c;ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13&#x201d;</div>), which improves the disclosure requirements for fair value measurements. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13</div> is effective for us beginning <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2020.</div> Early adoption is permitted for any removed or modified disclosures. We are currently evaluating the potential impact of adopting this guidance on our Condensed Consolidated Financial Statements.</div> <div style=" margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 45pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 2018, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15</div> &#x201c;Intangibles-Goodwill and Other-Internal-Use Software (Subtopic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">350</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">40</div>): Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract&#x201d; (&#x201c;ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15&#x201d;</div>). ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15</div> aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15</div> is effective for us beginning <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November 1, 2020. </div>Early adoption is permitted. We are&nbsp;currently evaluating the potential impact of adopting this guidance on our Condensed Consolidated Financial Statements.</div></div>
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.49
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.93
CY2020Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
9456000
CY2020Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
2000
CY2019Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
15000
CY2020Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
9250000
CY2019Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
CY2020Q1 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0
CY2019Q1 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0
CY2019Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
CY2019Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
100000
CY2020Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7436000
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17106000
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1540000
CY2019Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
9562000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1712000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
346000
CY2020Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-2000
CY2019Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
6000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-32122000
CY2019Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-63013000
CY2020Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
1714000
CY2019Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
341000
CY2020Q1 us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
-2560000
CY2019Q1 us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
409000
CY2020Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
11818000
CY2019Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-17477000
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6058000
CY2019Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
100912000
CY2020Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
4437000
CY2019Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1331000
CY2020Q1 us-gaap Interest Paid
InterestPaid
770000
CY2019Q1 us-gaap Interest Paid
InterestPaid
689000
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
13955000
CY2019Q1 us-gaap Interest Paid Net
InterestPaidNet
40439000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
27802000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
1791000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1128000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
3447000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
6725000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
7894000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
6817000
CY2020Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
4496000
CY2020Q1 us-gaap Liabilities
Liabilities
2289082000
CY2019Q4 us-gaap Liabilities
Liabilities
2371200000
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1790003000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1881424000
CY2020Q1 us-gaap Loans Pledged As Collateral
LoansPledgedAsCollateral
74400000
CY2019Q4 us-gaap Loans Pledged As Collateral
LoansPledgedAsCollateral
143200000
CY2020Q1 us-gaap Long Term Debt
LongTermDebt
1460200000
CY2019Q4 us-gaap Long Term Debt
LongTermDebt
1479990000
CY2020Q1 us-gaap Minority Interest
MinorityInterest
700000
CY2019Q4 us-gaap Minority Interest
MinorityInterest
687000
CY2019Q4 us-gaap Mortgage Loans On Real Estate Writedown Or Reserve Amount1
MortgageLoansOnRealEstateWritedownOrReserveAmount1
1268000
CY2018Q4 us-gaap Mortgage Loans On Real Estate Writedown Or Reserve Amount1
MortgageLoansOnRealEstateWritedownOrReserveAmount1
2563000
CY2020Q1 us-gaap Mortgage Loans On Real Estate Writedown Or Reserve Amount1
MortgageLoansOnRealEstateWritedownOrReserveAmount1
1308000
CY2019Q1 us-gaap Mortgage Loans On Real Estate Writedown Or Reserve Amount1
MortgageLoansOnRealEstateWritedownOrReserveAmount1
1264000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-65159000
CY2019Q4 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
140000000
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
38959000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-16803000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3394000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
27644000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-122172000
CY2020Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
2591000
CY2020Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.096
CY2020Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y255D
CY2020Q1 us-gaap Other Commitment
OtherCommitment
11500000
CY2020Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-194000
CY2019Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-242000
CY2020Q1 us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
268465000
CY2019Q1 us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
190916000
CY2020Q1 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
18524000
CY2019Q1 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
1329000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
809000
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1019000
CY2020Q1 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
140000000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000
CY2020Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
5600
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
5600
CY2020Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
5600
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
5600
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
135299000
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
135299000
CY2020Q1 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
2521000
CY2019Q1 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
5727000
CY2020Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
60437000
CY2019Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
54216000
CY2020Q1 us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
345183000
CY2019Q1 us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
256161000
CY2020Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
9000
CY2019Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
15000
CY2019Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
89371000
CY2018Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
95064000
CY2020Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
89905000
CY2019Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
93410000
CY2020Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
3665000
CY2019Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
6091000
CY2020Q1 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
355000
CY2019Q1 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
251000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-9148000
CY2019Q1 us-gaap Profit Loss
ProfitLoss
-17452000
CY2020Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
40000
CY2019Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
41000
CY2019Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
71264000
CY2018Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
68117000
CY2020Q1 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
67879000
CY2019Q1 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
74455000
CY2020Q1 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
18136000
CY2019Q1 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
10242000
CY2020Q1 us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
44334000
CY2019Q1 us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
38853000
CY2020Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
58725000
CY2019Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
28264000
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1235121000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1225973000
CY2020Q1 us-gaap Revenues
Revenues
494056000
CY2019Q1 us-gaap Revenues
Revenues
380594000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-499779000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-490463000
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-499079000
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-489776000
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-453504000
CY2019Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-470364000
CY2020Q1 us-gaap Treasury Stock Value
TreasuryStockValue
115360000
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
115360000
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6161000
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5958000

Files In Submission

Name View Source Status
0001437749-20-004524-index-headers.html Edgar Link pending
0001437749-20-004524-index.html Edgar Link pending
0001437749-20-004524.txt Edgar Link pending
0001437749-20-004524-xbrl.zip Edgar Link pending
ex_168867.htm Edgar Link pending
ex_168868.htm Edgar Link pending
ex_168869.htm Edgar Link pending
ex_168870.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
hov-20200131.xml Edgar Link completed
hov-20200131.xsd Edgar Link pending
hov-20200131_cal.xml Edgar Link unprocessable
hov-20200131_def.xml Edgar Link unprocessable
hov-20200131_lab.xml Edgar Link unprocessable
hov-20200131_pre.xml Edgar Link unprocessable
hov20200131_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending